Comorbid substance use disorders may complicate treatment for both the hepatologist and psychiatrist. Comprehensive assessment of psychiatric illness and psychopharmacological management may be critical.
Lorenzo Rossaro, MD
Advertisement
Articles by Lorenzo Rossaro, MD
Advertisement
Latest Updated Articles
- Depression as Co-Pilot: Clinical Implications of Hepatitis C and Interferon/Ribavirin Treatment
Published: April 1st 2005 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Vagus Nerve Stimulation in Treatment Resistant Depression: New Lines of Thinking
2
Glutamatergic Pathways in Major Depressive Disorder: Insights From Juan D. Oms, MD, FAPA
3
Improving Outcomes in Schizophrenia With Long-Acting Injectables: Insights from the Southern Florida Psychiatry Conference
4
Pharmacologic Management of Stuttering: What Psychiatrists Need to Know
5
